Organigram Global (OGI) Competitors $1.73 +0.06 (+3.59%) Closing price 04:00 PM EasternExtended Trading$1.72 0.00 (-0.29%) As of 05:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OGI vs. ACB, CGC, CRON, SNDL, TLRY, VFF, TNGX, BGM, MNMD, and PHATShould you be buying Organigram Global stock or one of its competitors? The main competitors of Organigram Global include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), Tango Therapeutics (TNGX), BGM Group (BGM), Mind Medicine (MindMed) (MNMD), and Phathom Pharmaceuticals (PHAT). Organigram Global vs. Its Competitors Aurora Cannabis Canopy Growth Cronos Group SNDL Tilray Brands Village Farms International Tango Therapeutics BGM Group Mind Medicine (MindMed) Phathom Pharmaceuticals Aurora Cannabis (NASDAQ:ACB) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, valuation, earnings and dividends. Which has more volatility & risk, ACB or OGI? Aurora Cannabis has a beta of 1.84, meaning that its share price is 84% more volatile than the S&P 500. Comparatively, Organigram Global has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500. Do institutionals & insiders have more ownership in ACB or OGI? 47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Comparatively, 0.1% of Organigram Global shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is ACB or OGI more profitable? Organigram Global has a net margin of 2.86% compared to Aurora Cannabis' net margin of -5.66%. Aurora Cannabis' return on equity of -1.49% beat Organigram Global's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis-5.66% -1.49% -1.06% Organigram Global 2.86%-8.19%-5.79% Do analysts rate ACB or OGI? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.00Organigram Global 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has higher valuation & earnings, ACB or OGI? Aurora Cannabis has higher revenue and earnings than Organigram Global. Aurora Cannabis is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$357.88M0.89$1.63M-$0.19-29.58Organigram Global$117.47M1.97-$33.39M$0.0534.60 Does the media prefer ACB or OGI? In the previous week, Aurora Cannabis had 2 more articles in the media than Organigram Global. MarketBeat recorded 3 mentions for Aurora Cannabis and 1 mentions for Organigram Global. Aurora Cannabis' average media sentiment score of 1.19 beat Organigram Global's score of 0.29 indicating that Aurora Cannabis is being referred to more favorably in the media. Company Overall Sentiment Aurora Cannabis Positive Organigram Global Neutral SummaryAurora Cannabis beats Organigram Global on 11 of the 16 factors compared between the two stocks. Get Organigram Global News Delivered to You Automatically Sign up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGI vs. The Competition Export to ExcelMetricOrganigram GlobalMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$231.91M$10.59B$5.76B$9.84BDividend YieldN/A1.86%3.95%4.02%P/E Ratio34.6121.6931.3126.60Price / Sales1.9730.57461.30121.37Price / CashN/A24.9437.7659.36Price / Book0.833.5110.026.67Net Income-$33.39M$210.11M$3.27B$265.59M7 Day Performance10.19%5.11%3.17%3.42%1 Month Performance16.89%11.53%4.34%1.09%1 Year Performance-5.98%-6.20%44.11%23.85% Organigram Global Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGIOrganigram Global0.4022 of 5 stars$1.73+3.6%N/A-8.7%$231.91M$117.47M34.61860ACBAurora Cannabis0.949 of 5 stars$5.12+0.8%N/A-13.6%$286.79M$246.72M-26.951,130Positive NewsCGCCanopy Growth0.2874 of 5 stars$1.37+5.4%N/A-72.9%$311.80M$225.65M-0.453,150Options VolumeCRONCronos Group0.7843 of 5 stars$2.53+6.8%N/A+16.4%$907.80M$117.61M50.60450News CoverageSNDLSNDL1.9204 of 5 stars$2.16+6.9%$4.00+85.2%+29.1%$530.81M$671.81M-8.002,516TLRYTilray Brands1.8659 of 5 stars$1.14+10.7%$1.92+68.1%-21.7%$1.13B$821.31M-0.492,842Trending NewsAnalyst ForecastOptions VolumeGap UpVFFVillage Farms International1.4902 of 5 stars$2.90+12.8%N/A+200.0%$289.49M$336.18M32.231,400Positive NewsTNGXTango Therapeutics1.8338 of 5 stars$7.22+6.6%$10.33+43.1%-39.5%$753.23M$42.07M-5.4390Insider TradeBGMBGM GroupN/A$8.15+7.7%N/A+49.1%$735.97M$25.10M0.00298Positive NewsMNMDMind Medicine (MindMed)2.6697 of 5 stars$9.75+1.5%$24.71+153.5%+58.1%$731.21MN/A-6.3740Positive NewsPHATPhathom Pharmaceuticals2.5587 of 5 stars$10.10-1.4%$17.50+73.3%-20.9%$726.46M$55.25M-2.14110 Related Companies and Tools Related Companies ACB Competitors CGC Competitors CRON Competitors SNDL Competitors TLRY Competitors VFF Competitors TNGX Competitors BGM Competitors MNMD Competitors PHAT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OGI) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Global Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access